Document is current
Any future updates will be listed below
-
Authors
Jaeger, Judith
Staats, Kim A.
Barnum, Sarah
Pope, Parris
Kingery, Lisle
Buitendyk, Melanie
Cohen, Sharon
Tansey, Malú Gámez
Tesi, Raymond J.
Barnum, Christopher J.
- License Information
-
More Information
Article History
Received: 24 September 2025
Accepted: 2 April 2026
First Online: 13 May 2026
Competing interests
: J.J. is the owner of CognitionMetrics, LLC. CognitionMetrics provided scientific consulting services to INmune Bio. K.A.S., P.P., and C.J.B. are or were employees of INmune Bio, and hold shares in INmune Bio. S.B. and L.K. are paid consultants of INmune Bio. M.B. declares no financial or non-financial competing interests. S.C. was a site investigator for the MINDFuL study and has no financial interests. M.G.T. is a co-inventor of XPro1595, is a paid advisor to INmune Bio, and holds a financial stake in INmune Bio. M.G.T. is EIC of npj Parkinson’s disease. M.G.T. was not involved in the journal’s review of, or decisions related to, this manuscript. R.J.T. was a founder, CEO, and Board member of INmune Bio and holds shares in INmune Bio, but declares no competing interests.
